Streptozocin-diabetic rats show reduced hyperthermic effects but maintained anti-allodynia responses to the TRPV1 antagonist ABT-102 throughout nine days of dosing
Research output: Contribution to conference › Poster › peer-review
Fingerprint
Dive into the research topics of 'Streptozocin-diabetic rats show reduced hyperthermic effects but maintained anti-allodynia responses to the TRPV1 antagonist ABT-102 throughout nine days of dosing'. Together they form a unique fingerprint.